Free Trial
→ Trump doesn’t give a damn (From Porter & Company) (Ad) Free JSPR Stock Alerts

Jasper Therapeutics (JSPR) SEC Filings & 10K Form

Jasper Therapeutics logo
$5.97 -0.19 (-3.12%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$6.06 +0.10 (+1.63%)
As of 02/21/2025 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Jasper Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
01/08/2025
6:05 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
7:02 PM		Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Mahal Jeetinder Singh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2024
7:02 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
5:01 PM		Avidity Partners Management LP (Filed by)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Form SC 13G/A
11/07/2024
6:42 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:30 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
11:05 AM		Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SC 13G/A
10/22/2024
5:06 PM		BlackRock, Inc. (Filed by)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Form SC 13G
10/15/2024
5:03 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
4:18 PM		Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Mahal Jeetinder Singh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
4:19 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
6:00 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/20/2024
5:02 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
5:05 AM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Lucas Svetlana (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2024
5:07 AM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Lucas Svetlana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
8:40 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
8:31 PM		Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Mahal Jeetinder Singh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
7:00 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
5:25 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Shizuru Judith Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:28 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Nolet Chris (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:30 PM		French Anna Louise (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:31 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Tucker Edwin Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:15 PM		EMSTER KURT VON (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:17 PM		Brun Scott C. (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:20 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
WIGGANS THOMAS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:24 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Kapoor Vishal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:01 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form S-8 POS
06/07/2024
4:04 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form S-8 POS
06/07/2024
4:07 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form S-8 POS
05/14/2024
12:53 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2024
5:07 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form DEFA14A
04/22/2024
12:53 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form ARS
04/22/2024
12:37 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form DEFA14A
04/22/2024
12:13 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form DEF 14A
03/27/2024
3:26 PM		Avidity Partners Management LP (Filed by)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Form SC 13G
03/12/2024
8:33 PM		Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:50 PM		Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Mahal Jeetinder Singh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
4:49 PM		Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Lis William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
3:52 PM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/04/2024
6:40 AM		Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:JSPR) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIED
Robert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...
NewMarket Health Publishing, LLC. | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Grab This Altcoin Before Trump's Crypto Announcement
Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...
Crypto 101 Media | Sponsored
Why Buffett and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this win...
Behind the Markets | Sponsored
Market down? Do this now.
During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...
Colonial Metals | Sponsored
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored